China visits Belgium's UCB as part of wider pharma probe

07/22/2013 | Reuters

Officials from China's State Administration for Industry & Commerce visited UCB, a Belgium-based drugmaker, as part of widened investigations of allegations of bribery by drugmakers. "They've been launching inspections with several pharma companies active in the country, both Chinese and foreign companies such as ours, and as part of the process our Shanghai office was visited by the agency in the last 48 hours," a spokesman for UCB said.

View Full Article in:


Published in Briefs: